BioCentury
ARTICLE | Clinical News

Gynevac: Phase III started

June 30, 2014 7:00 AM UTC

AmVac began a double-blind, placebo-controlled, Hungarian Phase III trial to evaluate intramuscular Gynevac in 240 patients. AmVac said a previous version of Gynevac containing thiomersal -- a mercury...